GPEI Polio

GPEI Polio

Polio this week as of 27 April 2022
Headlines
:: This week, Global Polio Eradication Initiative (GPEI) partners launched the ‘Investment Case’ for polio eradication, at a virtual event.  The Investment Case is the GPEI sister-document to the Polio Eradication Strategy 2022-2026, and outlines the humanitarian and economic benefits of polio eradication.  During the event, the Government of Germany, which holds G7 presidency in 2022, announced that the country will co-host a pledging moment for the GPEI Strategy during the 2022 World Health Summit in October.  A recording of the virtual event is available online here.

:: Rotary International President Shekhar Mehta, WHO GPEI Director Aidan O’Leary and Dr Sarthak Das, Chief Executive Officer of the Asia Pacific Leaders Malaria Alliance offer their views on what lessons and experiences from polio and malaria can be drawn for existing and future pandemics, in an op-ed published in Health Policy Watch.  Read it here.
:: Comprehensive outbreak response in Tajikistan successfully stops outbreak:  an outbreak response assessment concluded that a cVDPV2 outbreak that started in January 2021 has been stopped, thanks to comprehensive and rapid response with novel oral polio vaccine type 2 (nOPV2).  More

 

Summary of new polioviruses this week:
– Pakistan: one WPV1 case and one positive environmental sample
– DR Congo: four cVDPV2 cases
– Israel: 13 cVDPV3 positive environmental samples
– Nigeria: one cVDPV2 case
– Occupied Palestinian territory: seven cVDPV3 positive environmental samples
– Somalia: one cVDPV2 case

 

Polio transition planning and polio post-certification
27 April 2022  Meeting report
Overview
The Executive Board at its 150th session noted an earlier version of this report.1 The present report provides an update on the implementation of the Strategic Action Plan on Polio Transition (2018–2023)2 at the start of 2022, within the context of the coronavirus disease (COVID-19) pandemic.